Subgroup analysis on the GI cancer location (Supplementary Figure S3) revealed an association favoring G-CSF prophylaxis in colorectal cancer (RR 0.24, 95% CI: 0.06–0.91, I2: 42%). This evidence concerns the gene CSF3 and colorectal cancer.